相关实验视频
Updated: Sep 17, 2025

10:05
Ganglioside Extraction, Purification and Profiling
Published on: March 12, 2021
4.7K
在GM2化酶中,等离子体膜重塑驱动突触功能障碍.
Alex S Nicholson1, David A Priestman2, Robin Antrobus1
1Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
PLoS biology
|July 3, 2025
概括
甘氨基脂 (GSLs) 的积累,就像甘地化物GM2一样,导致神经退行. 这项研究揭示了 lysosomal exocytosis 改变了神经元等离子体膜,影响了质化体的功能.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 葡萄糖脂 (GSL),包括大脑丰富的化物,是重要的生物活性膜成分.
- 团结体代谢的缺陷导致严重的早期神经退行,泰-萨克斯和桑德霍夫疾病是由于GM2积累而引起的.
- GM2积累的结果来自于非功能性的β-hexosaminidase A.
研究的目的:
- 为了研究基因转基因2相关的质化体中神经元功能障碍背后的细胞机制.
- 描述 GM2 储存对神经元等离子体膜组成和功能的影响.
- 探索 lysosomal exocytosis 在疾病发病过程中的作用.
主要方法:
- 开发基于i3神经元的疾病模型,用于类病.
- 分析GM2储存和内溶体功能障碍.
- 评估血脂质和蛋白质组成.
- 研究突触蛋白质的变化和溶酶体蛋白质局部化.
主要成果:
- i3神经元模型表现出GM2储存和严重的内分泌体功能障碍.
- 观察到血脂质和蛋白质组成的显著变化.
- lysosomal exocytosis 被确定为细胞表面上 lysosomal 蛋白质积累的一个驱动因素.
- 突触蛋白丰度发生变化,影响神经元活动.
- 血膜上溶解体蛋白质的丰富也在GM1球性粉症模型中观察到.
结论:
- 团性化症的特点是严重的等离子体膜疾病,由 lysosomal exocytosis 驱动.
- lysosomal exocytosis 有助于改变了血膜蛋白质组和神经元功能障碍.
- 这些发现为神经退行提供了对神经退行机制的洞察力,并对其他溶解体和神经退行性疾病有影响.
相关概念视频
Enlargement of the Plasma Membrane
2.0K
Cell division and enlargement are processes that require precise control. The control ensures that cell division cannot proceed unless the cell has grown to a specific size. A spherical, dividing cell requires an approximately 1.6X increase in its surface area to double its volume. The secretory pathway also has a significant role in cell membrane enlargement. Secretory vesicles that bud off from the Golgi apparatus and later fuse with the plasma membrane during exocytosis are a major source of...
2.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
456
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
456

